SPOTLIGHT -
The Big Sell: Biologics In Emerging Markets
High priced biologics may have a bright future in emerging markets, but winning access in the short term will be a hard sell.
Specialty Therapies Lose Special Status
Future savings from specialty pharmacies will come at pharma companies' expense.